Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-01-11 @ 4:36 AM
Study NCT ID:
NCT02576951
Status:
COMPLETED
Last Update Posted:
2019-02-26
First Post:
2015-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Galcanezumab in Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-14
First Submit QC Date:
None
Study First Post Date:
2015-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-19
Results First Submit QC Date:
None
Results First Post Date:
2019-02-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2019-02-26
Last Update Post Date Type:
ACTUAL